pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments

Area of Science:

• Biomedical Imaging
• Theranostics
• Drug Delivery

Background:

• Accurate monitoring of therapeutic efficacy is crucial for personalized cancer treatment.
• Existing methods for evaluating drug response often lack real-time, in vivo capabilities.
• Tumor microenvironment pH changes can indicate therapeutic effectiveness.

Purpose of the Study:

• To develop a novel pH-sensitive ratiometric fluorescent imaging probe for real-time monitoring of anti-cancer drug efficacy.
• To assess the probe's ability to penetrate cell membranes and image intracellular pH.
• To evaluate the probe's performance in tracking tumor pharmacodynamics in vivo.

Main Methods:

• Constructed a pH-sensitive ratiometric fluorescent probe (TAT-ANNA) by conjugating the dye ANNA to a cell-penetrating peptide (TAT).
• Performed in vitro experiments to confirm cellular uptake and intracellular pH imaging capabilities.
• Conducted in vivo studies to monitor the probe's ratiometric pH response in tumors post-medication.

Main Results:

• The TAT-ANNA probe demonstrated successful cell membrane penetration.
• Real-time intracellular pH imaging was achieved in vitro.
• The probe effectively recorded tumor pH changes in vivo immediately after anti-cancer drug administration, reflecting therapeutic response.

Conclusions:

• The TAT-ANNA probe is a viable tool for real-time, in vivo monitoring of anti-cancer drug pharmacodynamics.
• This imaging approach offers a promising strategy for precision theranostics in oncology.
• The probe's pH sensitivity allows for immediate assessment of tumor response to treatment.